DRGEM is making a move to capture the next-generation medical imaging equipment market.


DRGEM Obtains Domestic Manufacturing Certification for AI-Powered Mobile C-arm 'PROVUE' View original image

On July 7, DRGEM announced that it recently obtained domestic manufacturing certification for three models: PROVUE-5S, PROVUE-15S, and PROVUE-5A. With this certification, the company has been recognized for compliance with safety and quality management requirements under relevant laws, laying the foundation not only for the domestic market but also for global market expansion.


As a mobile C-arm uses X-rays in real time during procedures, its core competitive strength lies in minimizing radiation exposure while providing clear images.


During the development of PROVUE, DRGEM applied an AI-based image processing engine, making real-time fluoroscopy possible even in environments with low tube voltage and current. This has enabled the company to reduce radiation exposure for both medical staff and patients, while securing the image quality necessary for accurate diagnosis.


In particular, a denoising algorithm developed in collaboration with KAIST has been applied. This technology is designed to effectively reduce image noise generated in low-dose imaging environments, enabling clear X-ray images while lowering radiation dosage. The company expects this will further strengthen its technological competitiveness in the fluoroscopy device market.


With this manufacturing certification as a starting point, DRGEM will begin full-scale commercialization of the PROVUE product line. The company plans to accelerate follow-up development and mass production preparations, aiming for an official global launch of PROVUE in the second half of 2026. In addition, DRGEM intends to expand its portfolio of mobile imaging equipment and enhance its overseas market strategy by leveraging AI-based medical image processing technology.



Park Jeongbyeong, CEO of DRGEM, stated, "This PROVUE domestic manufacturing certification is a meaningful achievement that once again proves DRGEM's image processing technology and market competitiveness. Through continuous research and development and quality innovation, we will provide safer and more reliable medical imaging solutions to the healthcare field, and starting with PROVUE, we will continue to expand our next-generation medical imaging product portfolio to further strengthen our global market position."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing